Modular Medical, Inc. (MODD) is an innovative healthcare technology company that is revolutionizing the field of patient care and treatment management. The company's main objective is to build game-changing products that enable healthcare providers to manage and monitor patients' treatment regimen with more efficiency and precision. With the company's unique platform, healthcare professionals can modify and adjust medical treatment plans based on the patient's response and feedback. This comprehensive ability to individualize care plans is something that sets MODD apart in the medical industry.
One of the most known products by MODD is Pancreum, a sophisticated artificial pancreas system that is designed to revolutionize the management of insulin-dependent diabetes. The system is designed to mimic the function of the human pancreas by delivering precise doses of insulin to the patient based on real-time glucose values. This approach provides a streamlined way for diabetes patients to manage their condition, empowering them with an unprecedented level of precision and control.
Modular Medical has strategically positioned itself at the forefront of the digital healthcare revolution, using technology to improve the delivery of care, improve patient outcomes, and drive down healthcare costs. The innovative company is using its transformative products to change the face of medical care and improve the lives of patients around the world.
Modular Medical, Inc. is much more than just a healthcare technology company. It serves as a testament to how technology and innovation can pave the way for advancements in healthcare, transforming the way patient care is delivered and managed. It is an institution that fosters continuous innovations in the field of medicine by creating and implementing modular solutions that promote efficiency and individualized treatment approaches.
MODD is committed to maintaining their position as an industry-leading innovator, continually investing in research and development to stay ahead of the curve. Their focus on creating products that seamlessly merge with existing healthcare systems is a testament to their dedication to enhancing patient care and ensuring accessibility for all.
This industry pioneer is undoubtedly shaping the future of patient healthcare. With its impressive track record of developing revolutionary products and its dedication to improving patient outcomes, Modular Medical, Inc. represents the future of patient care and treatment management. The company's novel approach has drastically improved the lives of many patients, affirming its position as a key player in modern healthcare evolution.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Modular Medical has signed a contract with a national U.S. pharmacy benefit manager for its Pivot insulin delivery system, aiming to improve patient access and boost commercialization. The Pivot system is a wearable, tubeless insulin delivery device with recent FDA clearance for software enhancements that expand dosing flexibility. Despite a 7.60% stock increase, market volatility was noted as shares fell in after-hours trading.
Modular Medical (NASDAQ: MODD) has received FDA clearance for software enhancements to its Pivot insulin delivery system. These upgrades expand functionality, offering users greater flexibility in bolus dosing and an improved user interface, ahead of the planned fourth-quarter launch. The company also recently initiated the first phase of commercialization for its tubeless patch pump in selected U.S. markets.
Modular Medical, Inc. (NASDAQ:MODD) has secured a contract with a national U.S. pharmacy benefit manager (PBM) for its Pivot™ tubeless patch pump. This agreement aims to broaden patient access to the insulin delivery system, validating the Pivot pump as an accessible therapeutic option for individuals with diabetes. The company emphasizes the critical role PBMs play in facilitating patient access to medical technologies and believes this partnership will simplify insulin delivery for more patients.
Modular Medical, Inc. announced a contract with a national U.S. pharmacy benefit manager (PBM) for its Pivot™ tubeless patch pump insulin delivery system. This agreement is a significant commercialization milestone, aiming to expand patient access to the device for individuals with diabetes. PBM partnerships are crucial for facilitating access to innovative medical technologies by streamlining reimbursement and increasing awareness.